Search Results - "DAB, I"

Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis by App, E.M, Baran, D, Dab, I, Malfroot, A, Coffiner, M, Vanderbist, F, King, M

“…The aim of the present studies was to investigate the tolerability and activity of a novel mucolytic drug, Nacystelyn (NAL), for the treatment of cystic…”
Get full text

Differential cytology of bronchoalveolar lavage fluid in asthmatic children by Najafi, N., Demanet, C., Dab, I., De Waele, M., Malfroot, A.

“…Although asthma usually begins in childhood, limited information is available as to the inflammatory reaction of asthmatic children compared to adults and the…”
Get full text

New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up by Malfroot, A, Dab, I

“…A higher frequency (25%) of gastrooesophageal reflux (GOR) has been previously reported in patients over 5 years old with cystic fibrosis compared with…”
Get full text

The long-term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease by VANDENPLAS, Y, HAUSER, B, VAN DEN BORRE, C, CLYBOUW, C, MAHLER, T, HACHIMI-IDRISSI, S, DERAEVE, L, MALFROOT, A, DAB, I

“…At the age of 5 years, the prevalence of atopic manifestations was analysed in 58 formula-fed "at risk" infants because of a history of atopic disease in at…”
Get full text

Respiratory Syncytial Virus Lung Infection in Infants: Immunoregulatory Role of Infected Alveolar Macrophages by Midulla, Fabio, Villani, Alberto, Panuska, James R., Dab, Isi, Kolls, Jay K., Merolla, Rocco, Ronchetti, Roberto

“…Thirteen previously healthy children with acute onset of severe lower respiratory tract signs and symptoms underwent bronchoscopy and bronchoalveolar lavage…”
Get full text

Left ventricular perfusion deficit in patients with cystic fibrosis by De Wolf, Daniel, Franken, P., Piepsz, A., Dab, I.

“…Left ventricular failure is not considered an important feature in cystic fibrosis (CF), but abnormalities of left ventricular function have been reported…”
Get full text

Thoracoscopic T2-T3 sympathicolysis for essential hyperhidrosis in childhood: Effects on pulmonary function by Noppen, Marc, Dab, I., D'Haese, J., Meysman, M., Vincken, W.

“…Thoracoscopic T2‐T3 sympathicolysis (TS) is a minimally invasive treatment for patients suffering from severe, refractory essential hyperhidrosis (EH). TS has…”
Get full text

A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children by Desager, J P, Dab, I, Horsmans, Y, Harvengt, C

“…The pharmacokinetics of the second-generation H1-receptor antagonist cetirizine was studied in eight children younger than 4 years of age who were treated with…”
Get more information

Corticosteroids in primary tuberculosis with bronchial obstruction by Toppet, M, Malfroot, A, Derde, M P, Toppet, V, Spehl, M, Dab, I

“…The usefulness of prednisolone in combination with the modern potent antituberculous drugs has been studied in 29 children with primary lung tuberculosis and…”
Get full text

Gastroesophageal reflux: a primary defect in cystic fibrosis? by Dab, I, Malfroot, A

“…Ten infants and newborns with recently and successively diagnosed cystic fibrosis (CF) were investigated for possible gastroesophageal reflux (GER) by means of…”
Get more information

Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children by Malfroot, A, Vandenplas, Y, Verlinden, M, Piepsz, A, Dab, I

“…Thirty-eight children, aged from a few weeks to 7 years, with severe chronic pulmonary disease and without gastrointestinal symptoms, were investigated for…”
Get more information

Nerve conduction in vitamin E deficient cystic fibrosis patients by De Schepper, J, Hachimi-Idrissi, S, Dab, I, Schmedding, E

Get full text

Bronchoalveolar lavage in children by Ers Task Force on bronchoalveolar lavage in children

Get full text

Mild cystic fibrosis in child homozygous for G542 non-sense mutation in CF gene by Bonduelle, M, Lissens, W, Liebaers, I, Malfroot, A, Dab, I

Get more information

Successful management of recurrent pneumothorax in cystic fibrosis by localized apical thoracoscopic talc poudrage by Noppen, M, Dhondt, E, Mahler, T, Malfroot, A, Dab, I, Vincken, W

“…Thoracoscopic talc poudrage of the entire pleural surface constitutes successful treatment of recurrent pneumothorax in cystic fibrosis (CF); however,…”
Get more information

A serine to proline substitution (S1255P) in the second nucleotide binding fold of the cystic fibrosis gene by Lissens, W, Bonduelle, M, Malfroot, A, Dab, I, Liebaers, I

Get more information

Oral glucose tolerance testing in cystic fibrosis : correlations with clinical parameters and glycosylated haemoglobin determinations by DESCHEPPER, J, DAB, I, DERDE, M. P, LOEB, H

“…In 48 patients (age 2-28 years) with documented cystic fibrosis, glucose tolerance was evaluated by means of an oral glucose tolerance test (OGTT) and repeated…”
Get full text

Tuberculosis in children : a 13-year follow up of 1714 patients in a Belgian home care centre by TOPPET, M, MALFROOT, A, HOFMAN, B, CASIMIR, G, CANTRAINE, F, DAB, I

“…From May 1970 to September 1983, 1714 children with different forms of primary tuberculosis were referred to the paediatric home care centre (Enfants soignés…”
Get full text

First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters by De Schepper, J, Hachimi-Idrissi, S, Smitz, J, Dab, I, Loeb, H

“…Adult patients with cystic fibrosis (CF) are at high risk for developing insulin-dependent diabetes mellitus. Therefore, the fast insulin release (FIR) to…”
Get more information

Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium by Revets, H, Vandamme, P, Van Zeebroeck, A, De Boeck, K, Struelens, M J, Verhaegen, J, Ursi, J P, Verschraegen, G, Franckx, H, Malfroot, A, Dab, I, Lauwers, S

“…Burkholderia cepacia has become an increasingly recognized pathogen among cystic fibrosis (CF) patients and its potential role in declining pulmonary function…”
Get more information